Role of Pindi-Ocular Poultice Kriyakalpa in the Management of dry eye

Optimization of Pindi- Ocular Poultice Kriyakalpa and its role in the Management of Sushkakshipaka-dry eye with special reference to Meibomian Gland Dysfunction

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047312

Enrollment

Registered

2022-11-15

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H118- Other specified disorders of conjunctiva

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.18 years and older patients of either sex. 2.Patients presenting with signs and symptoms of Shushkakshipaka. 3.Patients presenting with signs of MGD â?? a.Ocular dryness. b.Lid margin thickening or irregularity. c.Meibomian gland orifice plugging. d.Cloudy, yellow or frothy meibomian gland secretions. e.Lid margin telangiectasia. f.Meibomian gland capping. 4.TBUT- 5.Schirmer â??test-

Exclusion criteria

Exclusion criteria: 1.Cases complicated with acute, chronic, infective conjunctivitis any specific eyelid disorder, corneal ulcer, dacryocystitis and lagophthalmos. 2.Inflammatory diseases unrelated to MGD. 3.Patients suffering from any systemic disorder or taking any medications which in the opinion of PI may affect the clinical outcome of the trial. 4.Contact lenses use. 5.History of ocular surgery within 6 months prior to enrollment in trial.etc

Design outcomes

Primary

Measure	Time frame
To evaluate the role of Optimized pindi kriya kalp on shushkakshipaka w.s.r. to MGD.tTimepoint: 21 days	—

Secondary

Measure	Time frame
Optimization of Pindi (ocular poultice) kriya kalp procedure.Timepoint: 1 month	—

Countries

India

Contacts

Public ContactRam dayal

Institute Of Medical science BHU

dr_ks_dhiman@yahoo.co.in9599913738

Outcome results